QS Investors, LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 175 filers reported holding ANTARES PHARMA INC in Q4 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q2 2021$525,000
+6.1%
120,2000.0%0.01%0.0%
Q1 2021$495,000
+3.1%
120,2000.0%0.01%0.0%
Q4 2020$480,000
+47.7%
120,2000.0%0.01%
+50.0%
Q3 2020$325,000
-81.4%
120,200
-81.1%
0.00%
-83.3%
Q2 2020$1,745,000
+16.6%
634,400
+0.1%
0.02%0.0%
Q1 2020$1,496,000
-44.4%
633,800
+0.3%
0.02%
-11.1%
Q4 2019$2,692,000
+203.5%
631,700
+138.4%
0.03%
+170.0%
Q3 2019$887,000
+1.7%
265,0000.0%0.01%
+11.1%
Q2 2019$872,000
+8.6%
265,0000.0%0.01%0.0%
Q1 2019$803,000265,0000.01%
Other shareholders
ANTARES PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders